Skip to main content

Table 2 Outcomes in clinical face-to-face and digital visits at baseline and follow-up

From: Implementation of a hybrid healthcare model in rheumatic musculoskeletal diseases: 6-months results of the multicenter Digireuma study

 

Face-to-face visits

Digital visits

 

Baseline

6 months

Baseline

3 months

6 months

Rheumatoid Arthritis n  = 23

 DAS28

2.6 (2)

1.6 (1.8)

-

-

-

 TJC

1 (3.25)

0 (2)

1 (2)

1 (0.5)

1 (0.8)

 SJC

0.5 (2.5)

0 (2)

1 (1.5)

1 (0)

1 (0.8)

 HAQ

0.13 (0.9)

0.13 (0.63)

0.2 (0.5)

0.4 (0.4)

0.25(0. 4)

 PtGA

2 (4)

1.5 (3.5)

2 (1.7)

2 (2.5)

2 (0.8)

 VAS pain

4 (3)

1.35 (2.25)

3 (5)

1.5(1.2)

2 (1)

Spondyloarthritis n  = 24

 BASDAI

2.1 (3)

2.2 (3.6)

3.3 (5.3)

1.4 (4.2)

2.2(0.6)

 TJC

0 (1)

0 (2)

1 (1.75)

3.5(2.5)

2.5(0.6)

 SJC

0 (1)

0 (0.25)

3 (3.6)

1.5(1.75)

5 (4)

 PtGA

2 (3)

2 (4)

1 (1.5)

4.5 (3)

2.5(1.8)

 VAS pain

2.5 (3)

2 (3.25)

-

-

-

  1. DAS28 Disease Activity Score-28, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, TJC tender joint count, SJC swollen joint count, HAQ health assessment questionnaire, PtGA patient global assessment, VAS Visual analogue scale. Results are expressed in median (IQR)